Business intelligence

See the market beneath the medicine.

Market structure, pricing, ownership, service design and change over time for operators, investors, advisors and researchers in private-pay health.

Request accessAsk about advisory

What we measure

A shared evidence spine for commercial decisions.

Individual public records establish trust. Controlled products add scale, history, normalization and analysis.

01

Supply

Providers, locations, service lines, clinicians, care models and geographic density.

02

Economics

Prices, inclusions, exclusions, membership design, pass-through costs and contract terms.

03

Infrastructure

Pharmacies, lab channels, Fullscript, Rupa, technology and fulfillment relationships.

04

Structure

Ownership, franchise systems, expansion, leadership and operating-model signals.

05

Change

Dated snapshots, pricing movement, offering changes and category development.

06

Demand

Thresholded, aggregate intent signals without licensing consumer-level transaction records.

Reporting and delivery

From a market question to a usable answer.

Briefs and dashboards

  • Market and category maps
  • Pricing and offering benchmarks
  • Ownership and expansion signals
  • Coverage and methodology notes

Exports and feeds

  • Current snapshots
  • Historical and change datasets
  • CSV, XLSX and CRM-ready delivery
  • Field-level provenance

API and MCP

  • Authenticated queries
  • Entitled fields by customer
  • Dated answers with source context
  • No public browser payload of the full dataset

Custom intelligence

  • Commercial diligence
  • Market-entry research
  • Competitor and channel mapping
  • Ongoing monitoring
Explore advisory →

Intelligence cannot buy influence.

Data access does not purchase placement, ranking, a badge, favorable coverage or changes to the public record. Provider-submitted evidence is labeled and reviewed independently.

Confidential pricing, identifiable consumer contributions and license-restricted source material stay out of public and standard client delivery.

Start with the decision—not a data dump.

Tell us the market, geography and question. We’ll identify the right coverage, delivery format and evidence standard.

What decision should the intelligence support?

Contact details are used only to evaluate and respond to this request.

Peptide supply-chain evidence

648 dated regulatory records with source links and matching limitations.

Explore the evidence